Tao Zhu
Founder bei CANSINO BIOLOGICS INC.
Aktive Positionen von Tao Zhu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CANSINO BIOLOGICS INC. | Founder | 13.01.2009 | - |
| Chief Tech/Sci/R&D Officer | 13.01.2009 | - | |
| Director/Board Member | 13.01.2009 | 21.02.2024 | |
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Director/Board Member | 26.03.2020 | - |
| Independent Dir/Board Member | 26.03.2020 | - |
Karriereverlauf von Tao Zhu
Ehemalige bekannte Positionen von Tao Zhu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SANOFI | Corporate Officer/Principal | 01.01.2009 | 01.01.2009 |
Ausbildung von Tao Zhu
| Carnegie Mellon University | Doctorate Degree |
| University of Pittsburgh | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
Statistik
International
| China | 4 |
| Vereinigte Staaten | 3 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 2 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANOFI | Commercial Services |
| CANSINO BIOLOGICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
